no I couldn’t find any data in company presentations about pain relief with device. Maybe we’ll need to wait for further trial updates but agree with comments about confounders and placebo effects.
Went into OSL website a couple of days ago to look for Oncosil device official product label/ information /package insert or equivalent (like Sirtex has on its site) as this may have been informative about what BSI has approved, but couldn’t find it. Seems strange not to have it if device licensed for sale in Europe.
I did note they call the device an “adjuvant” treatment. That doesn’t make sense based on how it’s used; perhaps they don’t really understand what adjuvant means in oncology. But Will also hold for now.
Ann: Oncosil breakthrough device receives CE Marking approval, page-114
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $3.293K | 720.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 23973265 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 9017803 | 9 |
View Market Depth
| Last trade - 13.28pm 27/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |